Ads
related to: bcrx stock pricenerdwallet.com has been visited by 100K+ users in the past month
Search results
Wall Street Analysts Think BioCryst (BCRX) Could Surge 107.2%: Read This Before Placing a Bet
Zacks via Yahoo Finance· 11 months agoThe average of price targets set by Wall Street analysts indicates a potential upside of 107.2% in...
Investors might be losing patience for BioCryst Pharmaceuticals' (NASDAQ:BCRX) increasing losses, as...
Simply Wall St. via Yahoo Finance· 2 years agoInvesting can be hard but the potential fo an individual stock to pay off big time inspires us. But...
BioCryst Pharmaceuticals, Inc.'s (NASDAQ:BCRX) recent 18% pullback adds to one-year year losses,...
Simply Wall St. via Yahoo Finance· 7 months agoKey Insights Given the large stake in the stock by institutions, BioCryst Pharmaceuticals' stock...
BioCryst Pharmaceuticals (BCRX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Zacks via Yahoo Finance· 1 year agoBioCryst (BCRX) possesses the right combination of the two key ingredients for a likely earnings...
BioCryst Pharmaceuticals, Inc.'s (NASDAQ:BCRX) institutional shareholders had a great week as...
Simply Wall St. via Yahoo Finance· 1 year agoKey Insights Given the large stake in the stock by institutions, BioCryst Pharmaceuticals' stock...
BioCryst Pharmaceuticals (NASDAQ:BCRX) investors are sitting on a loss of 48% if they invested a...
Simply Wall St. via Yahoo Finance· 6 months agoBioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) shareholders should be happy to see the share price up...
BioCryst (BCRX) Surges 9.9%: Is This an Indication of Further Gains?
Zacks via Yahoo Finance· 9 months agoBioCryst (BCRX) saw its shares surge in the last session with trading volume being higher than...
With 80% ownership, BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) boasts of strong institutional...
Simply Wall St. via Yahoo Finance· 2 months agoKey Insights Significantly high institutional ownership implies BioCryst Pharmaceuticals' stock...
BioCryst Pharmaceuticals (BCRX) Reports Q3 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 2 years agoBioCryst (BCRX) delivered earnings and revenue surprises of 28.13% and 3.23%, respectively, for the...
Insider Buying: Charles Gayer Acquires 30,000 Shares of BioCryst Pharmaceuticals Inc (BCRX)
GuruFocus.com via Yahoo Finance· 1 month agoCharles Gayer, Chief Commercial Officer of BioCryst Pharmaceuticals Inc (NASDAQ:BCRX), purchased...
